Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Anasetti

Showing results (151-160 of 222) with videos related to

Pageof 23
Sort By:
Bone Marrow Transplantation|October 1, 1993
Autologous bone marrow transplantation for acute lymphoblastic leukemiaK Doney, C D Buckner, L Fisher, et al.
Bone Marrow Transplantation|January 1, 1992
Late complications of allogeneic and autologous marrow transplantationK M Sullivan, M Mori, J Sanders, et al.
Progress in Clinical and Biological Research|January 1, 1989
Long-term complications of bone marrow transplantationK M Sullivan, C D Buckner, J E Sanders, et al.
The New England Journal of Medicine|January 26, 1989
Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphomaC Anasetti, D Amos, P G Beatty, et al.
Blood|March 25, 2000
Unrelated donor marrow transplantation for chronic myelogenous leukemia: 9 years' experience of the national marrow donor programP B McGlave, X O Shu, W Wen, et al.
Blood|October 1, 1992
Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexateR A Nash, M S Pepe, R Storb, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1995
High-dose cyclophosphamide, carmustine, and etoposide followed by allogeneic bone marrow transplantation in patients with lymphoid malignancies who had received prior dose-limiting radiation therapyT Demirer, C H Weaver, C D Buckner, et al.
Blood|May 15, 1994
Unrelated donor or autologous marrow transplantation for treatment of acute leukemiaA Busca, C Anasetti, G Anderson, et al.
Bone Marrow Transplantation|November 18, 1998
Alloantigen presenting capacity, T cell alloreactivity and NK function of G-CSF-mobilized peripheral blood cellsD Rondelli, D Raspadori, C Anasetti, et al.
Transplantation|November 1, 1992
Treatment of acute graft-versus-host disease with a nonmitogenic anti-CD3 monoclonal antibodyC Anasetti, P J Martin, R Storb, et al.
Pageof 23

Showing results (151-160 of 222) with videos related to

Sort By:
Pageof 23
Bone Marrow Transplantation|October 1, 1993
Autologous bone marrow transplantation for acute lymphoblastic leukemiaK Doney, C D Buckner, L Fisher, et al.
Bone Marrow Transplantation|January 1, 1992
Late complications of allogeneic and autologous marrow transplantationK M Sullivan, M Mori, J Sanders, et al.
Progress in Clinical and Biological Research|January 1, 1989
Long-term complications of bone marrow transplantationK M Sullivan, C D Buckner, J E Sanders, et al.
The New England Journal of Medicine|January 26, 1989
Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphomaC Anasetti, D Amos, P G Beatty, et al.
Blood|March 25, 2000
Unrelated donor marrow transplantation for chronic myelogenous leukemia: 9 years' experience of the national marrow donor programP B McGlave, X O Shu, W Wen, et al.
Blood|October 1, 1992
Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexateR A Nash, M S Pepe, R Storb, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1995
High-dose cyclophosphamide, carmustine, and etoposide followed by allogeneic bone marrow transplantation in patients with lymphoid malignancies who had received prior dose-limiting radiation therapyT Demirer, C H Weaver, C D Buckner, et al.
Blood|May 15, 1994
Unrelated donor or autologous marrow transplantation for treatment of acute leukemiaA Busca, C Anasetti, G Anderson, et al.
Bone Marrow Transplantation|November 18, 1998
Alloantigen presenting capacity, T cell alloreactivity and NK function of G-CSF-mobilized peripheral blood cellsD Rondelli, D Raspadori, C Anasetti, et al.
Transplantation|November 1, 1992
Treatment of acute graft-versus-host disease with a nonmitogenic anti-CD3 monoclonal antibodyC Anasetti, P J Martin, R Storb, et al.
Pageof 23